Skip to main content
ImmuneCited

Vitamin and zinc status pretreatment and posttreatment in patients with inflammatory bowel disease.

Neha R Santucci, Razan H Alkhouri, Robert D Baker, Susan S Baker
Other Journal of pediatric gastroenterology and nutrition 2014 38 sitasi
PubMed DOI
<\/script>\n
`; }, get iframeSnippet() { const domain = 'immunecited.com'; const params = 'pmid\u003D25000354'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

Study Design

Jenis Studi
Observational Study
Ukuran Sampel
61
Populasi
Patients with inflammatory bowel disease
Durasi
260 weeks
Intervensi
Vitamin and zinc status pretreatment and posttreatment in patients with inflammatory bowel disease. None
Pembanding
None
Luaran Utama
Vitamin and zinc status in IBD patients
Arah Efek
Positive
Risiko Bias
Unclear

Abstract

Vitamin deficiencies are common in inflammatory bowel disease. Here we present 5-year follow-up data of 61 patients. No folate or vitamin B12 deficiency was identified throughout the study. A daily multivitamin supplement was sufficient to replete 100% of vitamin A-deficient and vitamin E-deficient patients. A total of 52% of vitamin D-deficient patients corrected, but 15% who had normal vitamin D levels at diagnosis developed deficiency. A total of 63% of zinc-deficient patients normalized their zinc status, but 15% developed zinc deficiency at follow-up despite supplementation.

TL;DR

A daily multivitamin supplement was sufficient to replete 100% of vitamin A–deficient and vitamin E-deficient patients and no folate or vitamin B12 deficiency was identified throughout the study.

Used In Evidence Reviews

Similar Papers